Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,996 | 110,845 | 116,616 | 123,794 | 146,877 |
| Receivables | 268,319 | 286,154 | 281,159 | 248,855 | 264,563 |
| Inventories | 204,893 | 196,876 | 189,468 | 173,303 | 179,684 |
| Other current assets | 126,174 | 118,423 | 110,403 | 108,220 | 113,073 |
| TOTAL | $703,382 | $712,298 | $697,646 | $654,172 | $704,197 |
| Non-Current Assets | |||||
| PPE Net | 496,584 | 469,982 | 449,103 | 437,270 | 409,980 |
| Intangibles | 247,833 | 253,146 | 254,016 | 256,314 | 258,466 |
| Other Non-Current Assets | 303,682 | 288,811 | 280,203 | 189,593 | 171,887 |
| TOTAL | $1,048,099 | $1,011,939 | $983,322 | $883,177 | $840,333 |
| Total Assets | $1,751,481 | $1,724,237 | $1,680,968 | $1,537,349 | $1,544,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 75,515 | 67,606 | 70,143 | 69,534 | 65,457 |
| Accrued Expenses | 278,626 | 256,329 | 229,127 | 260,683 | 238,431 |
| TOTAL | $626,627 | $618,909 | $689,619 | $770,444 | $759,537 |
| Non-Current Liabilities | |||||
| Long Term Debt | 696,634 | 700,552 | 699,334 | 601,348 | 664,963 |
| Deferred Revenues | 42,986 | 43,446 | 43,351 | 41,290 | 41,149 |
| Other Non-Current Liabilities | 143,418 | 148,688 | 151,491 | 84,787 | 81,531 |
| TOTAL | $922,132 | $933,779 | $939,479 | $776,138 | $786,356 |
| Total Liabilities | $1,548,759 | $1,552,688 | $1,629,098 | $1,546,582 | $1,545,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,783 | 86,090 | 86,006 | 86,007 | 86,234 |
| Common Shares | 10,559 | 10,548 | 10,535 | 10,509 | 10,504 |
| Retained earnings | 1,505,152 | 1,396,315 | 1,270,609 | 1,167,928 | 1,082,292 |
| Other shareholders' equity | -40,543 | -36,276 | -35,149 | -36,886 | -37,643 |
| TOTAL | $202,722 | $171,549 | $51,870 | $-9,233 | $-1,363 |
| Total Liabilities And Equity | $1,751,481 | $1,724,237 | $1,680,968 | $1,537,349 | $1,544,530 |